These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 21737024)
1. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024 [TBL] [Abstract][Full Text] [Related]
2. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients. Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086 [No Abstract] [Full Text] [Related]
3. Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants. Berglund S; Lönnerdal B; Westrup B; Domellöf M Am J Clin Nutr; 2011 Dec; 94(6):1553-61. PubMed ID: 22071701 [TBL] [Abstract][Full Text] [Related]
4. Perinatal role of hepcidin and iron homeostasis in full-term intrauterine growth-restricted infants. Briana DD; Boutsikou T; Baka S; Boutsikou M; Stamati L; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A Eur J Haematol; 2013 Jan; 90(1):37-44. PubMed ID: 23110713 [TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15. Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871 [TBL] [Abstract][Full Text] [Related]
6. Iron status in patients with chronic heart failure. Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in iron homeostasis in human experimental and clinical malaria. Woolley SD; Grigg MJ; Marquart L; Gower JSE; Piera K; Nair AS; Amante FM; Rajahram GS; William T; Frazer DM; Chalon S; McCarthy JS; Anstey NM; Barber BE EBioMedicine; 2024 Jul; 105():105189. PubMed ID: 38851058 [TBL] [Abstract][Full Text] [Related]
8. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia. Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811 [No Abstract] [Full Text] [Related]
9. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy. Garcia-Valdes L; Campoy C; Hayes H; Florido J; Rusanova I; Miranda MT; McArdle HJ Int J Obes (Lond); 2015 Apr; 39(4):571-8. PubMed ID: 25614087 [TBL] [Abstract][Full Text] [Related]
10. Hepcidin and iron deficiency in pre-kidney transplant patients. Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836 [TBL] [Abstract][Full Text] [Related]
11. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia. Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412 [TBL] [Abstract][Full Text] [Related]
12. Regulation of hepcidin: insights from biochemical analyses on human serum samples. Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212 [TBL] [Abstract][Full Text] [Related]
13. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851 [TBL] [Abstract][Full Text] [Related]
14. Iron Status and Homeostasis Across 2 Competitive Seasons in NCAA Division I Collegiate Cross-Country Runners Residing at Low Altitude. Goodrich JA; Frisco DJ; Kim S; VanBaak K; Holliday M; Rueda M; Poddar S; Byrnes WC Int J Sports Physiol Perform; 2022 Dec; 17(12):1716-1724. PubMed ID: 36343619 [TBL] [Abstract][Full Text] [Related]
15. Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants. Mendoza E; Duque X; Moran S; Martínez-Andrade G; Reyes-Maldonado E; Flores-Huerta S; Martinez H Ann Hematol; 2021 Apr; 100(4):879-890. PubMed ID: 33515046 [TBL] [Abstract][Full Text] [Related]
16. Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia. Bah A; Pasricha SR; Jallow MW; Sise EA; Wegmuller R; Armitage AE; Drakesmith H; Moore SE; Prentice AM J Nutr; 2017 Jun; 147(6):1131-1137. PubMed ID: 28424258 [No Abstract] [Full Text] [Related]
17. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Guo W; Bachman E; Li M; Roy CN; Blusztajn J; Wong S; Chan SY; Serra C; Jasuja R; Travison TG; Muckenthaler MU; Nemeth E; Bhasin S Aging Cell; 2013 Apr; 12(2):280-91. PubMed ID: 23399021 [TBL] [Abstract][Full Text] [Related]
18. Rheumatoid anemia. Masson C Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655 [TBL] [Abstract][Full Text] [Related]
19. Real-world experience of intravenous iron sucrose supplementation and dynamics of soluble transferrin receptor and hepcidin in a Spanish cohort of absolute iron deficient patients. Tarancon-Diez L; Iriarte-Gahete M; Sanchez-Mingo P; Perez-Cabeza G; Romero-Candau F; Pacheco YM; Leal M; Muñoz-Fernández MÁ Biomed Pharmacother; 2023 Nov; 167():115510. PubMed ID: 37757490 [TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure. Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]